Who Decides How AI Enters Pathology?
Liron Pantanowitz explains why validation, leadership, and real-world use matter more than performance metrics
By
Jessica Allerton
June 12, 2026
Clinical Scorecard: Who Decides How AI Enters Pathology?
At a Glance
Category Detail
Condition Key Mechanisms AI tools assist in identifying small metastatic foci in pathology slides. Target Population Care Setting
Key Highlights
Google AI's Lymph Node Assistant (LYNA) achieved high accuracy in detecting metastatic breast cancer. Clinical validation in real-world settings is essential before routine use of AI tools. Guideline-Based Recommendations
Diagnosis
AI tools should be validated in the local clinical environment before patient care. Management
Implementation should start with a clear clinical need. Monitoring & Follow-up
Ongoing monitoring for version changes or drift is necessary. Risks
Human oversight is important to define when AI can be relied upon. Patient & Prescribing Data
AI can support diagnostic tasks.
Clinical Best Practices
Ensure accurate annotation and establish consensus-based 'ground truth' for datasets. Promote diverse and representative datasets to reduce bias. Define expectations for explainability. Related Resources & Content
